-
公开(公告)号:ZA200304270B
公开(公告)日:2004-08-30
申请号:ZA200304270
申请日:2003-05-30
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , HASVOLD LISA A , LI TOMGMEI , MANTEI ROBERT A , SHAM HING L , TONG YUNSONG , WANG LE , WANG WEIBO , GWALTNEY STEPHEN L II , LI QUN , LIN NAN-HORNG , ROCKWAY TODD W , SULLIVAN GERARD M , WANG GARY T , WANG XILU
IPC: A61K20060101 , A61P20060101 , C07D20060101 , C07D , A61K , A61P
-
公开(公告)号:CA2470214A1
公开(公告)日:2003-06-26
申请号:CA2470214
申请日:2002-12-12
Applicant: ABBOTT LAB
Inventor: HUTCHINS CHARLES , GIRANDA VINCENT L , GONG JIANCHUN , STOLL VINCENT S , ABRAMS JASON N , DINGES JURGEN , ZHU GUI-DONG , DIEBOLD ROBERT , SONG XIAOHONG , ROSENBERG SAUL H , FISCHER JOHN P , LI QUN , GANDHI VIRAJ , WOODS KEITH W , PACKARD GARRICK , THOMAS SHEELA A , LI TONGMEI
IPC: C07D239/48 , A61K31/416 , A61K31/4365 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/502 , A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/52 , A61K31/5377 , A61P35/00 , A61P43/00 , C07D213/63 , C07D213/65 , C07D213/75 , C07D213/82 , C07D231/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D473/34 , C07D475/02 , C07D495/04 , C07D498/04
Abstract: Compounds having the formula (I), are useful for inhibiting protein kinases and for the treatment of cancer. Also disclosed are compositions which inhib it protein kinases and methods of inhibiting protein kinases in a patient.
-
公开(公告)号:PE20020687A1
公开(公告)日:2002-08-03
申请号:PE2001001198
申请日:2001-11-29
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , GWALTNEY II STEPHEN L , LI QUN , LIN NAN-HORNG , ROCKWAY TODD W , SULLIVAN GERARD M , WANG GARY T , WANG XILU , WANG WEIBO , WANG LE , TONG YUNSONG , SHAM HING L , MANTEI ROBERT A , LI TONGMEI , HASVOLD LISA A
IPC: A61K31/4164 , A61K31/4178 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/64 , C07D277/20 , C07D277/30 , C07D401/12 , C07D405/12 , C07D409/12 , C07D401/01
Abstract: SE REFIERE A IMIDAZOLES Y TIAZOLES DE FORMULA I DONDE E ES UN ANILLO CARBOCICLICO AROMATICO O NO AROMATICO DE CINCO, SEIS O SIETE MIEMBROS DONDE ENTRE 0-3 ATOMOS DE CARBONO ESTAN REEMPLAZADOS POR NITROGENO; F Y G SON C Y N CON LA SALVEDAD DE QUE CUANDO UNO DE F Y G ES N EL OTRO ES C; L1 Y L2 SON ALQUENILENO, ALQUINILENO, O, NR9, C(O), S, ENTRE OTROS; X ES S, NR7; R1 ES ARILO, ARILALQUILO, HETEROCICLO, (HETEROCICLO)ALQUILO; R2 ES H, ALCOXI, ALQUILO, AMINO, AMINOALQUILO, CIANO, CIANOALQUILO, ENTRE OTROS; R3 ES ARILO, HETEROCICLO Y CICLOALQUILO; R4-R6 SON H, NR9C(O), C(N)NR9, ALCANOILO, ALQUENILO, ENTRE OTROS; R7 ES H, ALQUILO, ARILO, CICLOALQUILO, ENTRE OTROS; R9 ES H, ALCOXIALQUILO, ALQUILO, AMIDOALQUILO, ENTRE OTROS; R12 ES H, ALCOXI, ALQUILO, ENTRE OTROS; m, n, p, q SON 0-4. SON COMPUESTOS PREFERIDOS 4-(((6-CLORO-2-(3-CLOROFENIL)-3-PIRIDINIL)METOXI)(1-METIL-1H-IMIDAZOL-5-IL)METIL)BENZONITRILO, 4-(((2-(3-CLOROFENIL)-6-METIL-3-PIRIDINIL)METOXI)(1-METIL-1H-IMIDAZOL-5-IL)METIL)BENZONITRILO, ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE LA FARNESIL TRANSFERASA Y SON UTILES PARA EL TRATAMIENTO DE TUMORES
-
公开(公告)号:ES2168740T3
公开(公告)日:2002-06-16
申请号:ES98904979
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
Abstract: A process for the preparation of a compound having the formula: wherein R1, R2, R3, R4, and R5 are defined, from an enamine by chain expansion and ring closure followed by additional derivatization, treatment with a 3-alkoxyl-acryloyl compound, another ring closure, and converting a hydroxyl group to a leaving group.
-
公开(公告)号:AT217309T
公开(公告)日:2002-05-15
申请号:AT94929998
申请日:1994-09-30
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , LI QUN , COOPER CURT S , FUNG ANTHONY K L , LEE CHEUK M , PLATTNER JACOB J
IPC: C07D491/052 , A61K31/40 , A61K31/435 , A61K31/495 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/61 , C07D213/68 , C07D455/02 , C07D471/04 , C07D491/107 , C07D491/113 , C07D491/16 , C07D519/00 , C07K5/06 , A61K31/535
Abstract: Antibacterical coumpounds having formula (I) and the pharmaceutically acceptable salts, esters and amides thereof, preferred examples of which include those coumpounds wherein R is cycloalkyl of from three to eight carbon atoms or substituted phenyl; R is selected from the group consisting of (a) halogen, (b) loweralkyl, (c) loweralkenyl, (d) cycloalkyl of from three to eight carbons, (e) cycloalkenyl of from four to eight carbons, (f) loweralkoxy, (g) aryloxy, (h) aryl(loweralkyl)oxy, (i) aryl(loweralkyl), (j) cycloalkyl(loweralkyl), (k) amino, (l) (loweralkyl)amino, (m) aryl(loweralkyl)amino, (n) hydroxy substituted (loweralkyl)amino, (o) phenyl, (p) substituted phenyl, (q) bicyclic nitrogen-containing heterocycle, (r) nitrogen-containingaromatic heterocycle, and (s) nitrogen-containing heterocycle having formula (Ia) where x is between zero and three; R is halogen; R is hydrogen, loweralkyl, a pharmaceutically acceptable cation, or a prodrug ester group; R is hydrogen, loweralkyl, halo(loweralkyl), or -NR R ; and R is loweralkyl, as wellas pharmaceutical compositions containing such compounds and the use of the same in the treatment of bacterial infections.
-
公开(公告)号:GR3034694T3
公开(公告)日:2001-01-31
申请号:GR20000402381
申请日:2000-10-27
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , LEE CHEUK M , LI QUN , COOPER CURT S , PLATTNER JACOB J
IPC: A61K31/435 , A61K31/47 , A61K31/505 , A61K31/535 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/68 , C07D455/02 , C07D471/04 , C07D471/08 , C07D491/10 , C07D491/16 , C07D495/16 , C07D519/00 , C07K5/06 , A61K31/44 , A61K31/495 , C07D239/70 , C07D279/12 , C07D413/00 , C07D417/00 , C07D491/00 , C07D498/00
-
公开(公告)号:CZ288199A3
公开(公告)日:1999-11-17
申请号:CZ288199
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSAIO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
Abstract: A process for the preparation of a compound having the formula: wherein R1, R2, R3, R4, and R5 are defined, from an enamine by chain expansion and ring closure followed by additional derivatization, treatment with a 3-alkoxyl-acryloyl compound, another ring closure, and converting a hydroxyl group to a leaving group.
-
公开(公告)号:TR9901956T2
公开(公告)日:1999-10-21
申请号:TR9901956
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
CPC classification number: C07D455/02
-
公开(公告)号:ZA979728B
公开(公告)日:1998-05-22
申请号:ZA979728
申请日:1997-10-29
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , LI QUN , CHU DANIEL T , HASVOLD LISA ANNE
IPC: C07D207/14 , C07D455/02 , C07D471/04 , C07D
Abstract: A process for the preparation of chiral 3-aminopyrrolidine and analogous bicyclic derivatives from dihydroxy olefins by treatment with titanium isopropoxide, an optically active tartrate ester and tert-butyl hydroperoxide, followed by subsequent alkylation of the intermediate with an alkyl or alkenyl magnesium halide, then pyrrolidine ring formation by condensation with an arylmethylamine, subsequent chiral replacement of a ring hydroxyl group with an amino group with further protection thereof, optional additional substitution closing of the second ring, and hydrogenolysis to remove a ring-nitrogen protecting group.
-
公开(公告)号:AU7925894A
公开(公告)日:1995-05-04
申请号:AU7925894
申请日:1994-09-30
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , LI QUN , COOPER CURT S , FUNG ANTHONY K L , LEE CHEUK M , PLATTNER JACOB J
IPC: C07D491/052 , A61K31/40 , A61K31/435 , A61K31/495 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/61 , C07D213/68 , C07D455/02 , C07D471/04 , C07D491/107 , C07D491/113 , C07D491/16 , C07D519/00 , C07K5/06 , A61K31/535
Abstract: Antibacterical coumpounds having formula (I) and the pharmaceutically acceptable salts, esters and amides thereof, preferred examples of which include those coumpounds wherein R is cycloalkyl of from three to eight carbon atoms or substituted phenyl; R is selected from the group consisting of (a) halogen, (b) loweralkyl, (c) loweralkenyl, (d) cycloalkyl of from three to eight carbons, (e) cycloalkenyl of from four to eight carbons, (f) loweralkoxy, (g) aryloxy, (h) aryl(loweralkyl)oxy, (i) aryl(loweralkyl), (j) cycloalkyl(loweralkyl), (k) amino, (l) (loweralkyl)amino, (m) aryl(loweralkyl)amino, (n) hydroxy substituted (loweralkyl)amino, (o) phenyl, (p) substituted phenyl, (q) bicyclic nitrogen-containing heterocycle, (r) nitrogen-containingaromatic heterocycle, and (s) nitrogen-containing heterocycle having formula (Ia) where x is between zero and three; R is halogen; R is hydrogen, loweralkyl, a pharmaceutically acceptable cation, or a prodrug ester group; R is hydrogen, loweralkyl, halo(loweralkyl), or -NR R ; and R is loweralkyl, as wellas pharmaceutical compositions containing such compounds and the use of the same in the treatment of bacterial infections.
-
-
-
-
-
-
-
-
-